20:13

Genetic Profiling of Multiple Myeloma

HMP Education

23:01

Novel Treatment Applications for Newly Diagnosed Patients Eligible for Transplant

HMP Education

34:13

Which is the Most Important Target for Monoclonal Antibodies in Myeloma Therapy?

HMP Education

30:45

Smoldering Multiple Myeloma – Defining High Risk and Deciding Who to Treat

HMP Education

21:55

Therapy Options for Transplant-ineligible Multiple Myeloma

HMP Education

13:28

Maintenance therapy or watchful waiting?

HMP Education

22:33

Emerging Therapeutic Options for Relapsed/Refractory Multiple Myeloma

HMP Education

25:02

Targeting Molecular and Genetic Abnormalities in CLL

HMP Education

24:11

How should anti-CD20 monoclonal antibodies be utilized in CLL?

HMP Education

25:12

Enhancing Clinical Outcomes in CLL through Selection of Optimal Frontline Therapy

HMP Education

23:29

Clinical Considerations for the Treatment of the Elderly CLL Patient

HMP Education

16:07

Treatment Strategies for Relapsed/Refractory CLL

HMP Education

26:11

Transplantation in CLL

HMP Education

10:24

DEBATE: Follicular Lymphoma - Treat

HMP Education

11:22

DEBATE: Follicular Lymphoma - Do Not Treat

HMP Education

21:15

Frontline Therapy for Advanced Follicular Lymphoma

HMP Education

23:56

New Possibilities for Relapsing Follicular Lymphoma

HMP Education

24:24

Double-hit DLBCL

HMP Education

16:21

Should R-CHOP Remain the Standard of Care for DLBCL?

HMP Education

19:56

Treatment Options for Transplant-ineligible Relapsed DLBCL Patients

HMP Education

22:58

Marginal Zone Lymphoma

HMP Education

27:36

Clinical Considerations for the Treatment of Elderly MCL Patients

HMP Education

19:42

T-cell Lymphoma

HMP Education

21:31

BCR Inhibitors in CLL and Lymphoma

HMP Education

25:24

PI3K inhibitors in CLL and lymphoma

HMP Education